MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway

Oncogene

Volumn 33, Issue 42, 2014, Pages 5017-5027

  Yu, T ^a   Liu, K ^a   Wu, Y ^b   Fan, J ^a   Chen, J ^a   Li, C ^a   Yang, Q ^a   Wang, Z ^a  

^a SICHUAN CANCER HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

cell proliferation; CXC chemokine receptor 4; lentivirus; microRNA 9; oral squamous cell carcinoma; wnt catenin pathway

Indexed keywords

3' UNTRANSLATED REGION; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; MICRORNA; MIRN92 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL; APOPTOSIS; BINDING SITE; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR VOLUME; WNT SIGNALING PATHWAY;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, NUDE; MICRORNAS; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; RECEPTORS, CXCR4; RNA INTERFERENCE; TUMOR BURDEN; WNT SIGNALING PATHWAY;

EID: 85028170021     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.448     Document Type: Article

References (47)

1. Kademani D. Oral cancer. Mayo Clin Proc 2007; 82: 878–887. DOI: 10.4065/82.7.878
2. Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century- the approach of WHO Global Programme. Commun Dent Oral Epidemiol 2003; 31: 3–23. DOI: 10.1046/j.2003.com122.x
3. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009; 13: 64. DOI: 10.1186/1756-9966-28-64
4. Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma: long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 2008; 46: 1–5. DOI: 10.1016/j.bjoms.2007.08.006
5. Hu J, He Y, Yan M, Zhu C, Ye W, Zhu H et al. Dose dependent activation of retinoic acid-inducible gene-I promotes both proliferation and apoptosis signals in human head and neck squamous cell carcinoma. PLoS One 2013; 8: e58273. DOI: 10.1371/journal.pone.0058273
6. Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K et al. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis. PLoS One 2013; 8: e56381. DOI: 10.1371/journal.pone.0056381
7. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350–355. DOI: 10.1038/nature02871
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004; 116: 281–297. DOI: 10.1016/S0092-8674(04)00045-5
9. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66: 7390–7394. DOI: 10.1158/0008-5472.CAN-06-0800
10. Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence 2010; 1: 6. DOI: 10.1186/1758-907X-1-6
11. Selcuklu SD, Donoghue MTA, Spillane C. MiR-21 as a key regulator of oncogenic processes. Biochem Soc T 2009; 37: 918–925. DOI: 10.1042/BST0370918
12. Li JS, Huang HZ, Sun LJ, Yang M, Pan CB, Chen WL et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009; 15: 3998–4008. DOI: 10.1158/1078-0432.CCR-08-3053
13. Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009; 30: 2059–2063. DOI: 10.1093/carcin/bgp277
14. Wong TS, Liu XB, Ho ACW, Yuen APW, Ng RWM, Wei WI. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008; 123: 251–257. DOI: 10.1002/ijc.23583
15. Jiang L, Liu XQ, Kolokythas A, Yu JS, Wang AX, Heidbreder CE et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010; 127: 505–512. DOI: 10.1002/ijc.25320
16. Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J et al. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2013; 431: 610–616. DOI: 10.1016/j.bbrc.2012.12.097
17. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737–2743. DOI: 10.1002/ijc.24638
18. Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 2012; 287: 29516–29528. DOI: 10.1074/jbc.M111.335943
19. Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A et al. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 2012; 226: 61–72. DOI: 10.1002/path.2964
20. Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C et al. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol 2013; S1574-7891: 00068–00069.
21. Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 2009; 19: 375–383. DOI: 10.1111/j.1750-3639.2008.00184.x
22. Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C et al. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012; 31: 5081–5089. DOI: 10.1038/onc.2012.15
23. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res 2010; 16: 2927–2931.
24. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761–1767. DOI: 10.1182/blood-2005-08-3182
25. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC. Structural basis of Wnt recognition by Frizzled. Science 2012; 337: 59–64. DOI: 10.1126/science.1222879
26. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167–179. DOI: 10.1146/annurev.med.59.053006.104707
27. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9: 775–789. DOI: 10.1038/nrd3179
28. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269. DOI: 10.1038/nrc1840
29. Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S et al. MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway. Oncol Rep 2012; 28: 961–968.
30. Jing L, Jia Y, Lu J, Han R, Li J, Wang S et al. MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling. Neuroreport 2011; 22: 206–211. DOI: 10.1097/WNR.0b013e328344a666
31. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065–7070. DOI: 10.1158/0008-5472.CAN-05-1783
32. Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F et al. Epigenetic inactivation of microRNA gene hsa-miR-9-1 in human breast cancer. J Pathol 2008; 214: 17–24. DOI: 10.1002/path.2251
33. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH et al. MicroRNA-mediated downregulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242–252. DOI: 10.2353/ajpath.2008.080009
34. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa1 Y. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 2011; 129: 2611–2620. DOI: 10.1002/ijc.25923
35. Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A et al. Genomewide profiling at methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 2008; 7: 1146–1156. DOI: 10.4161/cbt.7.7.6208
36. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J et al. Downregulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 2009; 28: 82. DOI: 10.1186/1756-9966-28-82
37. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008; 7: 35. DOI: 10.1186/1476-4598-7-35
38. Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL et al. Genomic organization and promoter characterization of human cxcr4 gene. FEBS Lett 1998; 426: 271–278. DOI: 10.1016/S0014-5793(98)00359-7
39. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4: 540–550. DOI: 10.1038/nrc1388
40. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000; 287: 1606–1609. DOI: 10.1126/science.287.5458.1606
41. Lowy AM, Fenoglio-Preiser C, Kim OJ, Kordich J, Gomez A, Knight J et al. Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol 2003; 10: 284–290. DOI: 10.1245/ASO.2003.05.003
42. Al-Aynati MM, Radulovich N, Riddell RH, Tsao MS. Epithelialcadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 2004; 10: 1235–1240. DOI: 10.1158/1078-0432.CCR-03-0087
43. Jin Z, Zhao C, Han X, Han Y. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression. BMC Cancer 2012; 12: 480. DOI: 10.1186/1471-2407-12-480
44. Choe Y, Pleasure SJ. Wnt signaling regulates intermediate precursor production in the postnatal dentate gyrus by regulating CXCR4 expression. Dev Neurosci 2012; 34: 502–514. DOI: 10.1159/000345353
45. Fracalossi AC, Silva Mde S, Oshima CT, Ribeiro DA. Wnt/beta-catenin signalling pathway following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Mol Pathol 2010; 88: 176–183. DOI: 10.1016/j.yexmp.2009.11.004
46. Farr GH, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 2000; 148: 691–702. DOI: 10.1083/jcb.148.4.691
47. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883–891. DOI: 10.1038/sj.bjc.6605570